Try our Advanced Search for more refined results

Jennifer L Saavedra v. Eli Lilly and Company

Track this case

Case overview

Case Number:

2:12-cv-09366

Court:

California Central

Nature of Suit:

Contract: Other

Multi Party Litigation:

Class Action

Judge:

Stephen V. Wilson

Firms

Companies

Sectors & Industries:

  1. February 13, 2018

    Eli Lilly Says Cymbalta Users Can't Reopen Axed Case

    Eli Lilly and Co. urged a California federal court Monday not to reopen a proposed class action alleging the drugmaker hid the withdrawal risks of the antidepressant Cymbalta, saying the proposed class voluntarily dismissed their suit knowing that a U.S. Supreme Court decision could block them from appealing.

  2. January 30, 2018

    Cymbalta Users Try To Revive Case After High Court Setback

    Users of the antidepressant Cymbalta urged a California federal court Monday to revive their proposed class action alleging Eli Lilly and Co. hid the drug's withdrawal risks, saying that a U.S. Supreme Court decision prevented the users from ever truly arguing their case.

  3. November 23, 2015

    Cymbalta Users Appeal To 9th Circ. In Withdrawal Suit

    Three consumers accusing Eli Lilly & Co. of failing to warn them of the withdrawal risks of its antidepressant Cymbalta appealed to the Ninth Circuit on Monday in an effort to overturn a California federal judge's rulings that they can't pursue an injunction or statewide classes.

  4. October 26, 2015

    Consumers Push For Dismissal In Eli Lilly Cymbalta Case

    Three consumers accusing Eli Lilly & Co. of concealing the withdrawal risks of its antidepressant Cymbalta pushed back against the company's argument that the voluntary dismissal of their case would unfairly prejudice it, telling a California federal judge that the company's contentions don't apply to a dismissal with prejudice.

  5. October 14, 2015

    Consumers Pulling A Fast One In Cymbalta Case, Eli Lilly Says

    Eli Lilly & Co. told a California federal judge Wednesday that three consumers accusing the company of concealing the withdrawal risks of its antidepressant Cymbalta are trying to drop their claims in a transparent bid for a second chance to appeal orders denying their motions for class certification.

  6. July 22, 2015

    Eli Lilly Dodges 2nd Cymbalta Label Class Cert. Bid

    A California federal judge on Tuesday for a second time refused to certify a proposed class of consumers who claim Eli Lilly & Co. concealed the withdrawal risks associated with its antidepressant Cymbalta, saying the plaintiffs can't show that the alleged misrepresentations caused them to overpay for the drug.

  7. June 09, 2015

    Eli Lilly Pushes To Toss Cymbalta Withdrawal Suits

    Eli Lilly & Co. told a California federal court Monday that plaintiffs in two suits accusing the drugmaker of downplaying the alleged withdrawal effects of its antidepressant Cymbalta had not unearthed any new information about the drug's clinical trials that supports their claims.

  8. June 02, 2015

    Class Tries Again For Cert. In Cymbalta Withdrawal Suit

    A proposed class of consumers who claim that Eli Lilly & Co. concealed the withdrawal risks associated with its antidepressant Cymbalta filed anew for class certification in California court on Monday, using a more "traditional" damages model after a judge shot down its first try.

  9. December 22, 2014

    Judge Denies Class Cert. In Cymbalta Withdrawal Risks Suit

    A California federal judge has denied class certification in a suit alleging that Eli Lilly & Co. downplayed the withdrawal risks of its antidepressant drug Cymbalta, saying that the plaintiffs' damages model was flawed because of complicating factors in the prescription drug market.

  10. April 29, 2013

    Eli Lilly Says It Warned Doctors Of Cymbalta 'Brain Zaps'

    Eli Lilly & Co. urged a California federal judge on Monday to toss a class action alleging inadequate labeling of its antidepressant Cymbalta, saying it sufficiently disclosed to doctors the risk that discontinuing use of the drug would cause "brain zaps" and other side effects.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!